Holen Sie sich die Stockscreener-App
81.48
0.75%
0.61
Handel nachbörslich:
81.48
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$80.87
Offen:
$80.86
24-Stunden-Volumen:
6.06M
Relative Volume:
0.94
Marktkapitalisierung:
$65.68B
Einnahmen:
$20.10B
Nettoeinkommen (Verlust:
$3.04B
KGV:
22.83
EPS:
3.569
Netto-Cashflow:
$3.44B
1W Leistung:
+4.88%
1M Leistung:
+5.85%
6M Leistung:
-11.03%
1J Leistung:
-6.84%
1-Tages-Spanne:
$79.85
$81.50
1-Wochen-Bereich:
$75.96
$81.50
52-Wochen-Spanne:
$74.55
$100.18
Colgate Palmolive Co Stock (CL) Company Profile
Firmenname
Colgate Palmolive Co
Sektor
Telefon
(212) 310-2000
Adresse
300 PARK AVE, NEW YORK, NY
Vergleichen Sie CL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
81.48 | 65.19B | 20.10B | 3.04B | 3.44B | 3.569 |
|
PG
Procter Gamble Co
|
141.87 | 330.72B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
64.20 | 138.12B | 64.99B | 6.71B | 6.53B | 2.74 |
|
EL
Estee Lauder Cos Inc
|
113.73 | 39.74B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KMB
Kimberly Clark Corp
|
97.92 | 32.81B | 18.08B | 1.81B | 1.67B | 5.904 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-11 | Herabstufung | Argus | Buy → Hold |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2024-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-24 | Eingeleitet | Piper Sandler | Overweight |
| 2024-09-16 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-09-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-23 | Eingeleitet | TD Cowen | Buy |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-03-01 | Fortgesetzt | Goldman | Buy |
| 2024-01-29 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-13 | Eingeleitet | Jefferies | Buy |
| 2023-10-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-17 | Eingeleitet | Citigroup | Buy |
| 2023-01-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-22 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-10-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-01 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-05-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-04-08 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-02-02 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-01-31 | Bestätigt | Citigroup | Neutral |
| 2022-01-31 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-31 | Bestätigt | Deutsche Bank | Buy |
| 2022-01-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-31 | Bestätigt | Wells Fargo | Underweight |
| 2021-12-16 | Eingeleitet | Redburn | Neutral |
| 2021-10-05 | Fortgesetzt | BofA Securities | Neutral |
| 2021-09-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-06-24 | Eingeleitet | UBS | Buy |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-02-01 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2021-01-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-01-26 | Hochstufung | Berenberg | Sell → Hold |
| 2021-01-20 | Eingeleitet | Bernstein | Underperform |
| 2021-01-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-07-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-03-27 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-27 | Hochstufung | SunTrust | Hold → Buy |
| 2020-03-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-03 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-02-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-12-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-10-16 | Eingeleitet | Berenberg | Sell |
| 2019-04-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-07 | Eingeleitet | Credit Suisse | Underperform |
| 2019-02-11 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2019-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2019-01-09 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-29 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Herabstufung | SunTrust | Buy → Hold |
| 2018-07-30 | Herabstufung | Macquarie | Outperform → Neutral |
| 2018-05-25 | Hochstufung | Argus | Hold → Buy |
| 2018-04-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Colgate Palmolive Co Aktie (CL) Neueste Nachrichten
Will Colgate Palmolive Company stock split again soonEarnings Performance Report & Scalable Portfolio Growth Methods - ulpravda.ru
Moving Averages: How Colgate Palmolive Company stock performs during Fed tightening cyclesJuly 2025 PostEarnings & Target Return Focused Picks - ulpravda.ru
Colgate-Palmolive (India) Limited's (NSE:COLPAL) Shareholders Might Be Looking For Exit - simplywall.st
Crest, Texas AG reach agreement on kids' toothpaste labeling - Austin American-Statesman
Proctor & Gamble reaches agreement with Texas on fluoride in children’s toothpaste - Yahoo
Piper Sandler sees Colgate-Palmolive growth accelerating in 2026 - MSN
CL: TD Cowen Lowers Price Target, Maintains 'Buy' Rating | CL St - GuruFocus
Does Colgate Palmolive Company stock trade at a discount to peersMarket Activity Summary & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Another class action claims Tom’s of Maine toothpaste contaminated with bacteria - Class Action Lawsuits
Colgate (CL) Adjusts Toothpaste Packaging Following Settlement - GuruFocus
Assessing Colgate-Palmolive (CL) Valuation As Renewed Interest Follows Steady Demand And Dividend Appeal - simplywall.st
Moran Wealth Management LLC Purchases 28,454 Shares of Colgate-Palmolive Company $CL - MarketBeat
Cerity Partners LLC Lowers Stock Position in Colgate-Palmolive Company $CL - MarketBeat
'I'm Not Buying It': Judge Pans 'Ridiculous' Colgate Argument - Law360
Calls of the Day: Disney, Colgate-Palmolive, First Solar, Toll Brothers, D.R. Horton and Amphenol - CNBC
Interview: Diana Schildhouse, chief data and analytics officer, Colgate-Palmolive - Computer Weekly
Piper Sandler Upgrades Colgate-Palmolive (CL) with 7.32% PT Incr - GuruFocus
Piper Sandler upgrades Colgate-Palmolive stock rating to Overweight By Investing.com - Investing.com Australia
Piper Sandler upgrades Colgate-Palmolive stock rating to Overweight - Investing.com
Colgate-Palmolive Company $CL Shares Sold by Adams Diversified Equity Fund Inc. - MarketBeat
Allspring Global Investments Holdings LLC Sells 83,071 Shares of Colgate-Palmolive Company $CL - MarketBeat
Piper Sandler sees Colgate-Palmolive growth accelerating in 2026 (CL:NYSE) - Seeking Alpha
Colgate-Palmolive (CL) Upgraded to Overweight by Piper Sandler - GuruFocus
Divergent Views Emerge on Colgate-Palmolive Stock - AD HOC NEWS
Annual Reports - Colgate-Palmolive
A Look Into Colgate-Palmolive Inc's Price Over Earnings - Benzinga
The Truth About Colgate-Palmolive Co: Why Everyone Is Suddenly Paying Attention - AD HOC NEWS
MSN Money - MSN
Colgate-Palmolive (CL) Remains Overweight as JPMorgan Sees Headwinds Easing in 2026 - Finviz
Full Text: Petitioner's Brief In Colgate-Palmolive. - Tax Notes
Is Colgate-Palmolive’s Earnings Beat Streak Reshaping Analyst Expectations And Its Investment Narrative (CL)? - Yahoo Finance
Colgate-Palmolive Company $CL Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Colgate Max White Review: Can This Drugstore Toothpaste Actually Make Your Smile Visibly Whiter? - AD HOC NEWS
Colgate announces major change impacting all of its toothpaste products: 'Addresses a longstanding ... challenge' - The Cool Down
Colgate-Palmolive Stock Brushes Up Against Its Highs: Defensive Darling Or Overpolished Trade? - AD HOC NEWS
Here's what to expect from Colgate-Palmolive's next earnings report - MSN
Colgate-Palmolive Stock Holds Its Ground As Defensive Trade Regains Shine - AD HOC NEWS
Here's What to Expect From Colgate-Palmolive's Next Earnings Report - Barchart.com
Dental EconomicsHere's What to Expect From Colgate-Palmolive's Next Earnings Report - FinancialContent
Lazard Freres Gestion S.A.S. Raises Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Green Toothpaste Tubes and the New Antitrust Battleground - Bloomberg.com
Palmolive Duschgel Review: The Surprisingly Luxurious Shower Gel Everyone’s Sleeping On - AD HOC NEWS
Colgate-Palmolive Stock Should Do Better in 2026, but That's Not Saying Much - AOL.com
Colgate-Palmolive Stock: Defensive Giant Holds Its Ground As Wall Street Stays Cautiously Bullish - AD HOC NEWS
Boston Trust Walden Corp Lowers Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook - Finviz
Hotel Toiletries Market to Boom Worldwide By 2025-2032 | Unilever PLC, Eco-Soap Bank, Colgate-Palmolive Company - openPR.com
Abacus FCF Advisors LLC Acquires 22,105 Shares of Colgate-Palmolive Company $CL - MarketBeat
Is Colgate's Productivity Program a Catalyst for Its Margins? - Nasdaq
CL (Colgate-Palmolive Co) 5-Year RORE % : 9.00% (As of Sep. 2025) - GuruFocus
PineStone Asset Management Inc. Boosts Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Finanzdaten der Colgate Palmolive Co-Aktie (CL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.14%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):